On Friday, Swiss pharmaceutical company Roche (RHHBY) announced it received emergency approval from the U.S. Food and Drug Administration for the use of its new diagnostic test for Covid-19, the disease caused by the novel coronavirus that was first identified in China near the end of 2019.
More specifically, the test kit can be used to detect cells of the virus...
RHHBY has seen two previous bump and run formations and is looking for a continuation with a third bump and run, indicated by the green fractal. These bumps form above the natural trend and a bearish reversal slowly follows. Again I recommend ‘Encyclopedia of Chart patterns’ By TN Bulkowski for anyone interested in learning some patterns.
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro...
AVERAGE ANALYSTS PRICE TARGET $38
AVERAGE ANALYSTS RECOMMENDATION overweight
P/E RATIO 19
SHORT INTEREST
COMPANY PROFILE
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology,...
Could consolidate a little but has a priority review PDUFA date of 8/18/19 for Enrectinib solid tumors and ROSI-positive non-small cell lung cancer. Also PDUFA date of 9/2/19 for Tecentriq plus chemo
On a large time frame. Roche is on a steady uptrend. Currently it is at the support which brings in very good opportunity for a buy in for Long term holdings (20years)
Hello Everyone,
I would like to share with you my idea regarding Roche. This is not a trade advice.
There are signs that stock price may increase for Roche SIX:ROG
RSI (14)
There is a strong primary trendline A-B on RSI, support trendline
- Point A (25/Oct/2017) was the lowest RSI (14) low since 10/Aug/2011 making it very significant RSI low (6+ years)
-...
Hello Everyone,
I would like to share with you my idea regarding Roche (SIX:ROG). This is not a trade advice.
There is a chance that Roche stock will continue to rise for some time and if following conditions are met, it can event break out and increase significantly. However, keep in mind that these primary trendlines are NOW resistance levels and only if...
![ROG: Roche primary trenline analysis (RSI, MACD, price) [Daily]](https://s3.tradingview.com/m/mGUkDG7z_mid.png "Roche primary trenline analysis (RSI, MACD, price) [Daily]")
![ROG: Roche primary trendline analysis [Monthly]](https://s3.tradingview.com/8/84pilKpz_mid.png "Roche primary trendline analysis [Monthly]")
